Eye Health News and Research

Latest Eye Health News and Research

Ameco Medical to commence clinical trials for PNT procedure's reimbursement approval

Sunridge International, announced today that Ameco Medical is preparing to start the short term clinical trials needed for reimbursement approval.

9 Dec 2010

Focused intervention on core social deficits of ASD in toddlers improves social, communication skills

Targeting the core social deficits of autism spectrum disorders in early intervention programs yielded sustained improvements in social and communication skills even in very young children who have ASD, according to a study funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study was published online December 8, 2010, in the Journal of Child Psychology and Psychiatry.

9 Dec 2010

Novel treatment strategy for social impairment of people with ASD

Eastern Virginia Medical School researchers have identified a potential novel treatment strategy for the social impairment of people with Autism Spectrum Disorders (ASD), an aspect of the condition that has a profound impact on quality of life.

9 Dec 2010

Dobkin's technique delays brain damage in heart attack victims

After a heart attack and the victim stops breathing, a process of irreversible brain damage starts to occur within 3 to 4 minutes. Or does it?

8 Dec 2010

American Society for Microbiology honors UTHealth biologist for significant contributions

Known nationally for her research into single-cell organisms that affect oral health, Millicent "Mimi" Goldschmidt, Ph.D., a professor of microbiology and molecular genetics at The University of Texas Health Science Center at Houston (UTHealth), has been selected to receive the 2011 American Society for Microbiology (ASM) Founders Distinguished Service Award.

8 Dec 2010

Vision community, FDA discuss use of PROs to improve labeling of ophthalmic treatments, products

The vision community is discussing with the Food and Drug Administration how vision-related patient-reported outcomes might be used in improving the labeling of ophthalmic treatments and products. The group — composed of researchers, clinicians, policymakers and representatives from industry and vision associations — attended a one-day symposium sponsored by the National Institutes of Health's National Eye Institute and the FDA on October 13, 2009.

8 Dec 2010

Microsurgical technique effective in removing acoustic tumors

Surgery to remove tumors under the brain known as acoustic neuromas produces favorable outcomes in the "vast majority" of patients, according to one of the largest studies of its kind.

8 Dec 2010

Cephalon, Mesoblast to develop, commercialize novel adult MPC therapeutics

Cephalon, Inc. and Mesoblast Limited, today announced they have entered into a strategic alliance to develop and commercialize novel adult Mesenchymal Precursor Stem Cell therapeutics for degenerative conditions of the cardiovascular and central nervous systems.

8 Dec 2010

QLT's oral synthetic retinoid granted orphan drug designation for treatment of Leber Congenital Amaurosis

QLT Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for QLT091001, its oral synthetic retinoid, for the treatment of Leber Congenital Amaurosis (LCA). LCA is an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.

8 Dec 2010

Researchers synthesize wound-healing peptides

Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.

8 Dec 2010

FDA grants QLT's QLT091001 orphan drug designation for treatment of Retinitis Pigmentosa

QLT Inc. today announced that QLT091001, the Company's oral synthetic retinoid, has been granted orphan drug designation for the treatment of Retinitis Pigmentosa (RP) from the U.S. Food and Drug Administration (FDA). This follows the FDA grant of orphan drug designation for QLT091001 for the treatment of Leber Congenital Amaurosis (LCA) also on December 7, 2010.

8 Dec 2010

Military health costs skyrocket

CNNMoney: "The cost of health care is blowing the top off the Pentagon's budget. Mirroring the private sector trend, expenses have skyrocketed within the military's health system. The military spent $19 billion on health care in 2001 — and $49 billion in 2010. The Department of Defense forecasts a continued rise of 5% to 7% a year.

8 Dec 2010

32% of UAE residents could have diabetes or prediabetes by 2020

One in three United Arab Emirates (UAE) residents could have diabetes or prediabetes by the end of the decade, according to a new analysis from international health and well-being company UnitedHealth Group, released today at the World Health Care Congress Middle East meeting in Abu Dhabi.

7 Dec 2010

Expansion of newborn screening throws some families on a journey of great uncertainty

Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.

7 Dec 2010

Calhoun Vision LAL Light Adjustable Lens for customized cataract surgery

Vision RejuvenationTM Victoria, a Canadian leader in advanced cataract and refractive lens exchange surgery has become the first centre in Canada to implant the world's first Light Adjustable Intraocular Lens.

7 Dec 2010

CSC's Leading Edge Forum: Disruptive technologies to reshape delivery of healthcare

CSC's Leading Edge Forum today released a report that identifies a new wave of disruptive technologies that will reshape the delivery of healthcare. These new technologies will help control costs while improving health by ushering in an era of wellness, self-monitoring, increased and earlier detection of disease, and more effective treatments.

7 Dec 2010

Marine life-inspired anti-microbial surfaces

Taking a leaf from animals like dolphins and pilot whales that are known to have anti-fouling skins, researchers from A*STAR's Industrial Consortium On Nanoimprint (ICON) are using nanotechnology to create synthetic, chemical-free, anti-bacterial surfaces. The surfaces can reduce infections caused by pathogens such as S. aureus and E. coli and can be used on common plastics, medical devices, lenses and even ship hulls. Conventional methods for preventing bacterial surface attachment may use potentially harmful metal ions, nanoparticles, chemicals or UV-radiation.

5 Dec 2010

University of Portland's school of engineering named after Bjork-Shiley heart valve inventor

University of Portland's school of engineering will now be known as the Donald P. Shiley School of Engineering in recognition of the late Donald Shiley, a 1951 graduate who was an engineer, inventor, entrepreneur, businessman, philanthropist and loving husband and father. Among his many groundbreaking inventions was the Bjork-Shiley heart valve, an innovative medical device that has been credited with saving more than a half million lives.

4 Dec 2010

Closer to restoring vision loss due to optic nerve damage

Damage to the optic nerve, connecting the eye with the brain, is a major cause of blindness. The most common culprit is glaucoma, estimated to affect more than 4 million Americans. There is currently no way to restore the lost vision, because the optic nerve, like other nerves in the mature central nervous system (CNS), cannot regenerate. Now, scientists at Children's Hospital Boston report achieving the greatest regeneration to date in the mammalian optic nerve.

4 Dec 2010

Tips to keep kids 'jingle belling' with safe toys

The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.

3 Dec 2010

Eye Health News and Research

Latest Eye Health News and Research

Ameco Medical to commence clinical trials for PNT procedure's reimbursement approval

Focused intervention on core social deficits of ASD in toddlers improves social, communication skills

Novel treatment strategy for social impairment of people with ASD

Dobkin's technique delays brain damage in heart attack victims

American Society for Microbiology honors UTHealth biologist for significant contributions

Vision community, FDA discuss use of PROs to improve labeling of ophthalmic treatments, products

Microsurgical technique effective in removing acoustic tumors

Cephalon, Mesoblast to develop, commercialize novel adult MPC therapeutics

QLT's oral synthetic retinoid granted orphan drug designation for treatment of Leber Congenital Amaurosis

Researchers synthesize wound-healing peptides

FDA grants QLT's QLT091001 orphan drug designation for treatment of Retinitis Pigmentosa

Military health costs skyrocket

32% of UAE residents could have diabetes or prediabetes by 2020

Expansion of newborn screening throws some families on a journey of great uncertainty

Calhoun Vision LAL Light Adjustable Lens for customized cataract surgery

CSC's Leading Edge Forum: Disruptive technologies to reshape delivery of healthcare

Marine life-inspired anti-microbial surfaces

University of Portland's school of engineering named after Bjork-Shiley heart valve inventor

Closer to restoring vision loss due to optic nerve damage

Tips to keep kids 'jingle belling' with safe toys

Genetics & Genomics - Second Edition eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in